Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial.

ABSTRACT:

SUBMITTER: Sharma M 

PROVIDER: S-EPMC10822143 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature